SCHEMBL21031532

SCHEMBL21031532

c1ccc2cc(-c3c4ccccc4c(-c4c5ccccc5nc5oc6ccccc6c45)c4ccccc34)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 5/20 0.41
▸ ESR2 Q92731 4/20 0.41
▸ TDP1 Q9NUW8 2/20 0.35
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ GRM4 Q14833 2/20 0.34
▸ GPR84 Q9NQS5 1/20 0.34
▸ CYP1A2 P05177 4/20 0.34
▸ SMN1; SMN2 Q16637 4/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CYP2C9 P11712 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21031288 0.93 ESR1 (0.43) ESR1ESR2TDP1CYP11B1CYP11B2
SCHEMBL25847833 0.84 ESR1 (0.44) ESR1ESR2CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL21030671 0.83 ESR1 (0.42) ESR1ESR2TDP1CYP1A2SMN1; SMN2
SCHEMBL21032080 0.83 ESR1 (0.42) ESR1ESR2L3MBTL1CYP1A2ALDH1A1
SCHEMBL21032078 0.83 ESR1 (0.44) ESR1ESR2TDP1CYP1A2SMN1; SMN2
SCHEMBL971500 0.80 ESR1 (0.61) ESR1ESR2TDP1CYP11B1CYP11B2
SCHEMBL21031284 0.80 ESR1 (0.40) ESR1ESR2TDP1CYP1A2ALDH1A1
SCHEMBL21031029 0.80 NPC1 (0.43) ESR1ESR2GRM4CYP1A2SMN1; SMN2
SCHEMBL25847831 0.80 ESR1 (0.41) ESR1ESR2L3MBTL1CYP1A2ALDH1A1
SCHEMBL21031283 0.79 ESR1 (0.39) ESR1ESR2TDP1L3MBTL1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 ESR1 448/4885ESR2 984/4885TDP1 3278/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 ESR1 448/4885ESR2 984/4885TDP1 3278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback